Literature DB >> 26213375

Increased oxidative stress and oxidative DNA damage in non-remission schizophrenia patients.

U Sertan Copoglu1, Osman Virit2, M Hanifi Kokacya3, Mustafa Orkmez4, Feridun Bulbul2, A Binnur Erbagci5, Murat Semiz6, Gokay Alpak2, Ahmet Unal2, Mustafa Ari3, Haluk A Savas2.   

Abstract

Increasing evidence shows that oxidative stress plays a role in the pathophysiology of schizophrenia. But there is not any study which examines the effects of oxidative stress on DNA in schizophrenia patients. Therefore we aimed to assess the oxidative stress levels and oxidative DNA damage in schizophrenia patients with and without symptomatic remission. A total of 64 schizophrenia patients (38 with symptomatic remission and 26 without symptomatic remission) and 80 healthy volunteers were included in the study. 8-hydroxydeoxyguanosine (8-OHdG), total oxidant status (TOS) and total antioxidant status (TAS) were measured in plasma. TOS, oxidative stress index (OSI) and 8-OHdG levels were significantly higher in non-remission schizophrenic (Non-R-Sch) patients than in the controls. TOS and OSI levels were significantly higher in remission schizophrenic (R-Sch) patients than in the controls. TAS level were significantly lower and TOS and OSI levels were significantly higher in R-Sch patients than in Non-R-Sch patients. Despite the ongoing oxidative stress in patients with both R-Sch and Non-R-Sch, oxidative DNA damage was higher in only Non-R-Sch patients compared to controls. It is suggested that oxidative stress can cause the disease via DNA damage, and oxidative stress plays a role in schizophrenia through oxidative DNA damage.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  8-hydroxydeoxyguanosine; Oxidative DNA damage; Oxidative stress; Schizophrenia; Symptomatic remission

Mesh:

Substances:

Year:  2015        PMID: 26213375     DOI: 10.1016/j.psychres.2015.07.036

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  20 in total

1.  Flavone protects HBE cells from DNA double-strand breaks caused by PM2.5.

Authors:  Xing Ren; Yong Tang; Jiameng Sun; Jianbo Feng; Leilei Chen; Huixi Chen; Sijing Zeng; Changhui Chen; Xinqiu Li; Haixia Zhu; Zhaojun Zeng
Journal:  Hum Cell       Date:  2017-11-22       Impact factor: 4.174

2.  Molecular mechanisms involved in the prevention and reversal of ketamine-induced schizophrenia-like behavior by rutin: the role of glutamic acid decarboxylase isoform-67, cholinergic, Nox-2-oxidative stress pathways in mice.

Authors:  Tolulope Olabode Oshodi; Benneth Ben-Azu; Ismail O Ishola; Abayomi Mayowa Ajayi; Osagie Emokpae; Solomon Umukoro
Journal:  Mol Biol Rep       Date:  2021-04-03       Impact factor: 2.316

3.  Redox Dysregulation in Schizophrenia Revealed by in vivo NAD+/NADH Measurement.

Authors:  Sang-Young Kim; Bruce M Cohen; Xi Chen; Scott E Lukas; Ann K Shinn; A Cagri Yuksel; Tao Li; Fei Du; Dost Öngür
Journal:  Schizophr Bull       Date:  2016-09-24       Impact factor: 9.306

Review 4.  DNA Damage in Major Psychiatric Diseases.

Authors:  Muhammad Ummear Raza; Turan Tufan; Yan Wang; Christopher Hill; Meng-Yang Zhu
Journal:  Neurotox Res       Date:  2016-04-28       Impact factor: 3.911

5.  Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia.

Authors:  Maju Mathew Koola; Samir Kumar Praharaj; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2019-05-17

6.  ROS-Induced DNA Damage Associates with Abundance of Mitochondrial DNA in White Blood Cells of the Untreated Schizophrenic Patients.

Authors:  I V Chestkov; E M Jestkova; E S Ershova; V G Golimbet; T V Lezheiko; N Yu Kolesina; O A Dolgikh; V L Izhevskaya; G P Kostyuk; S I Kutsev; N N Veiko; S V Kostyuk
Journal:  Oxid Med Cell Longev       Date:  2018-02-25       Impact factor: 6.543

7.  Nucks1 gene polymorphism rs823114 is associated with the positive symptoms and neurocognitive function of patients with schizophrenia in parts of southern China.

Authors:  Xia Wen; Xusan Xu; Xudong Luo; Jinwen Yin; Chunmei Liang; Jinyuan Zhu; Xueyan Nong; Xiudeng Zhu; Fan Ning; Shanshan Gu; Susu Xiong; Jiawu Fu; Dongjian Zhu; Zhun Dai; Dong Lv; Zhixiong Lin; Juda Lin; You Li; Guoda Ma; Yajun Wang
Journal:  Psychiatr Genet       Date:  2021-08-01       Impact factor: 2.458

Review 8.  DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond.

Authors:  Enni Markkanen; Urs Meyer; Grigory L Dianov
Journal:  Int J Mol Sci       Date:  2016-06-01       Impact factor: 5.923

9.  Relationship between neutrophil/lymphocyte ratio with oxidative stress and psychopathology in patients with schizophrenia.

Authors:  Burak Kulaksizoglu; Sibel Kulaksizoglu
Journal:  Neuropsychiatr Dis Treat       Date:  2016-08-12       Impact factor: 2.570

10.  Reduced Slc1a1 expression is associated with neuroinflammation and impaired sensorimotor gating and cognitive performance in mice: Implications for schizophrenia.

Authors:  Parisa Afshari; Wei-Dong Yao; Frank A Middleton
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.